Perceptive Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,395,017
| Closed | -$190M | – | 159 |
|
|
2020
Q3 | $190M | Hold |
1,395,017
| – | – | 2.78% | 9 |
|
|
2020
Q2 | $135M | Buy |
1,395,017
+80,808
| +6% | +$6.74M | 2.18% | 14 |
|
|
2020
Q1 | $61.6M | Buy |
1,314,209
+107,798
| +9% | +$6.91M | 1.6% | 15 |
|
|
2019
Q4 | $87.9M | Buy |
1,206,411
+75,900
| +7% | +$4.6M | 1.75% | 16 |
|
|
2019
Q3 | $59M | Buy |
1,130,511
+30,000
| +3% | +$1.6M | 1.59% | 18 |
|
|
2019
Q2 | $55.2M | Buy |
1,100,511
+112,000
| +11% | +$5.45M | 1.27% | 17 |
|
|
2019
Q1 | $51.4M | Sell |
988,511
-86,705
| -8% | -$3.99M | 1.45% | 21 |
|
|
2018
Q4 | $53.5M | Sell |
1,075,216
-13,953
| -1% | -$768K | 2.04% | 13 |
|
|
2018
Q3 | $71M | Hold |
1,089,169
| – | – | 1.9% | 13 |
|
|
2018
Q2 | $54.1M | Buy |
1,089,169
+254,490
| +30% | +$12.3M | 1.42% | 21 |
|
|
2018
Q1 | $40.7M | Buy |
834,679
+123,953
| +17% | +$6.44M | 1.14% | 23 |
|
|
2017
Q4 | $29.9M | Buy |
710,726
+160,009
| +29% | +$6.17M | 0.99% | 24 |
|
|
2017
Q3 | $23.6M | Sell |
550,717
-2,437
| -0.4% | -$77.7K | 0.9% | 26 |
|
|
2017
Q2 | $14.5M | Sell |
553,154
-71,540
| -11% | -$943K | 0.73% | 38 |
|
|
2017
Q1 | $8.21M | Hold |
624,694
| – | – | 0.47% | 46 |
|
|
2016
Q4 | $8.09M | Sell |
624,694
-10,200
| -2% | -$157K | 0.58% | 44 |
|
|
2016
Q3 | $10.4M | Buy |
634,894
+132,000
| +26% | +$2.38M | 0.67% | 39 |
|
|
2016
Q2 | $6.24M | Hold |
502,894
| – | – | 0.43% | 51 |
|
|
2016
Q1 | $5.38M | Sell |
502,894
-9
| -0% | -$82 | 0.47% | 54 |
|
|
2015
Q4 | $7.37M | Buy |
+502,903
| New | +$6.15M | 0.55% | 44 |
|
Perceptive Advisors's MYOK Position: Q4 2020 in Review
Perceptive Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 1,395,017 shares — an estimated $190M sold.
Perceptive Advisors first reported a position in MYOK in Q4 2015 and held it in 20 quarters. The position peaked at $190M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Perceptive Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Perceptive Advisors sold 1,395,017 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $190M.
- Perceptive Advisors first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- Perceptive Advisors's MyoKardia, Inc. Common Stock position peaked at $190M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Perceptive Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.